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Abstract
Background: This study sheds important light on the association between sino-nasal symptoms and global quality
of life in patients with chronic rhinosinusitis waiting for endoscopic sinus surgery. Using patient-reported
information collected pre-operatively, the primary objective was to report on patients’ pre-surgical sino-nasal
symptoms and their association with self-reported pain and depression. The secondary objective was to report on
levels of depression and pain among patients in the sample reporting severe sleep problems.
Methods: This is a cross-sectional study of patient-reported outcomes collected prospectively from a cohort of 261
patients assigned to the wait list for elective endoscopic sinus surgery in a large urban region of Canada.
Results: Younger patients and patients with other medical comorbidities were most likely to report significant
symptoms of chronic rhinosinusitis and substantial associated pain and depression. In the primary analyses, patients
reporting significant symptoms of chronic rhinosinusitis were more likely to report moderate depression or high
pain (p < 0.01). Subsequently, chronic rhinosinusitis patients with severe sleep problems were 82% likely to report
moderate or severe depression and pain.
Conclusion: Preoperative management of depression and pain may be considered in order to improve the health-
related quality of life of patients waiting for ESS. As depression and pain were highly prevalent, patients with severe
sleep problems may be candidates for prioritized access.
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Background
The syndrome of chronic rhinosinusitis (CRS) is a het-
erogeneous cluster of sino-nasal symptoms associated
with mucosal inflammation. First line treatment for CRS
includes medical/pharmacological interventions, such as
steroids (topical and/or systemic) and antibiotics. It is
estimated that more than 5% of the Canadian population
suffer from CRS-related symptoms, resulting in almost
one million prescriptions per year [1, 2] and cause sig-
nificant demands on provincial health care systems.
Many patients with CRS eventually fail pharmaco-
logical intervention and progress to endoscopic sinus
surgery (ESS) for treatment. This is problematic for
many provincial health care systems, where demand for
elective (scheduled) surgery outstrips supply which, in
turn, results in substantial wait times for CRS patients.
For example, in 2016, Nova Scotia reported the median
wait time for ESS of approximately 4 months [3] – similar
median wait times have been reported in British Columbia
(BC) [4]. Wait times are not unique to ESS, as
Canada lags many of its peer countries in access to
specialized care [5] – despite significant investments,
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wait times for elective surgery continue to be a major
policy issue for provincial governments [6–8].
To manage those patients awaiting elective surgery, re-
gional health authorities in Canada use wait lists. These
wait lists are registries for elective surgeries, recording
demographics, diagnosis, surgery and date information –
including the date that patients were assigned to the
wait list and the date of their scheduled surgery. The
Achilles heel of the wait list is that very little is known
regarding symptom severity or the health status of those
patients in the registry. As previous study into the wait
list registry has observed, there is no relationship be-
tween the self-reported severity of patients’ symptoms
and their level of triage on the wait list [9].
The discordance between the severity of patients’
symptoms and the length of time they wait for surgery is
concerning, particularly in the case of CRS. Sino-nasal
symptoms have been documented to be associated with
significant anxiety and depression [10, 11]; especially in
patients without polyps [11], and more than half of pa-
tients with CRS reportedly suffer from pain [12, 13].
Dysfunction of sleep and pain have been seen to be
inter-related in the presence of depression [13]. How-
ever, very little is known about the health status of those
patients with CRS on the wait list for ESS, representing
a significant knowledge gap that can impair clinical
decision making.
To address this knowledge gap, the purpose of this de-
scriptive study is to measure the symptom burden and
the prevalence of pain or depression among CRS pa-
tients waiting for ESS after failed medical management.
Previous work has established a need for this informa-
tion in order to identify opportunities to improve the
health status of waiting patients [14].
To do so, this study uses validated patient-reported
outcomes (PROs) designed to systematically measure the
severity of symptom and functional impairments. The
primary analyses is to measure the association between
depression or pain with patients’ self-reported symptoms
of chronic rhinosinusitis. The secondary objective is ex-
plore emerging findings regarding relationship between
self-reported sleep problems with depression or pain
[15]. The results from cross-sectional analyses of PROs
could be used to identify potential gaps in patients’ care
while waiting for ESS and potentially provide insight
into policies for refining surgical wait times.
Methods
PROs were prospectively collected from a cohort of CRS
patients assigned to the surgical wait list for ESS in the
Vancouver Coastal Health (VCH) Authority, a region
encompassing Vancouver, Canada – home to over one
million residents. Vancouver Coastal Health is responsible
for managing the wait list for elective surgeries performed
in its acute hospitals.
The population of potential study participants in-
cluded all patients newly enrolled on VCH’s wait list for
bilateral endoscopic sino-nasal surgery with a surgeon
identified diagnosis of ‘chronic sinusitis/nasal polyposis’.
Specific surgical codes are provided in Additional file 1.
Potential participants were identified from VCH’s wait
list registry, which includes patients’ contact information.
A VCH surveyor contacted potential participants using a
standardized telephone script within 2 weeks of being
enrolled on the wait list. To be eligible, patients had to
be community-dwelling, 19 years or older, scheduled for
surgery at least 14 days from being enrolled on the wait
list, and able to respond (with or without assistance) to
survey questions in English. Patients agreeing to partici-
pate were sent the initial survey package, which included
survey instructions, the PRO instruments, and a stamped
return envelope.
Comorbidity information was collected from partici-
pants using a checklist of common chronic and acute con-
ditions. Age and sex was collected via the wait list from
participants and non-participants; these groups were com-
pared based on available demographic information. This
study reports on participants’ cross-sectional PROs data
collected between September 2012 and April 2016. The
University of British Columbia’s Behavioral Research
Ethics Board (BREB) approved the study.
Instruments
A number of different PRO instruments were completed
by participants, including the Sino-Nasal Outcomes Test
(SNOT)-22, the Patient Health Questionnaire (PHQ)-9,
and the PEG, representing pain intensity (P) and inter-
ference with enjoyment of life (E) and general activity
(G). The SNOT-22 was used to measure the severity of
CRS-related symptoms. The SNOT-22 is a widely used in-
strument that has previously demonstrated strong validity,
reliability, responsiveness, and ease of interpretation [16].
As its name implies, it is comprised of 22 items scored
from 0 to 5. The scores for each item are aggregated to
arrive at a global score that ranges from 0 (i.e., perfect
health) to 110 (i.e., worst health). The average SNOT-22
score in a healthy non-symptomatic adult is 7 [17].
Depression in patients was measured using the PHQ-9
[18]. This PRO instrument assesses depression in two
dimensions: symptoms and functional impairment. It
includes nine items, each of which is scored using a
four-point Likert scale ranging from 0 (i.e., “Not at all
bothered”) to 3 (i.e., “Bothered nearly every day”). The
score for each item is aggregated to arrive at a global
score that ranges from 0 to 27. PHQ-9 scores of 10, 15
and 20 represent, respectively, moderate, moderately se-
vere, and severe depression [18].
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The PEG was used to measure comorbid pain [19].
The PEG has three items; one representing pain inten-
sity and two items for interference. Each item is scored
on a 0–10 scale. The overall score is reported as the
average of the three items, and scores greater than three
have been indicative of high level of pain [20].
Statistical analysis
Anonymized data was analyzed using SAS 9.4 (Cary,
NC). Age and gender sub-groups were compared be-
tween participants and non-participants to ascertain
possible participant bias. Univariate analyses of the
SNOT-22 score were presented overall, by age group,
gender and count of reported comorbidities. Few partici-
pants reported more than three chronic health condi-
tions, so comorbidity data was categorized into counts
of 0, 1, 2, 3 and greater than 3.
Depression scores (PHQ-9) and pain scores (PEG)
were summarized, presented using cut-points validated
in the literature [18, 20]. Participants’ depression and
pain scores were examined relative to their SNOT-22
scores to provide in-depth insight into associations
between CRS symptoms and general health.
Independent multivariate models were used to meas-
ure associations between patients’ SNOT-22 score with
their PHQ-9 and PEG scores and other variables in the
three models, including age, sex and category of count
of comorbidity. Residuals were assessed visually to detect
departures from the models’ assumptions. P-values for
the regression models were reported. Since the analyses
were exploratory, no attempt was made to adjust p-values
for multiple comparisons.
A linear model was used to analyze SNOT-22 scores
to measure whether there was an association between
SNOT-22 scores with PHQ-9 depression or PEG pain
scores, after adjusting for age, sex and comorbidities.
The PHQ-9 and PEG scores were included in the
analysis of covariance model as continuous variables.
P-values were reported after assessing goodness of fit.
Patients’ sleep quality was evaluated. The SNOT-22
sleep score was calculated as the sum of the items asso-
ciated with sleep quality, items 11–18. The sleep score
ranged from 0 to 40, where a score of 40 represented
the worst state of sleep health-related quality of life.
Patients’ sleep scores were stratified by cut-points of the
PHQ-9 and PEG representing moderate depression and
high pain, respectively. For each quintile of SNOT-22
sleep score, mean (and standard deviation) PHQ-9 and
PEG scores were calculated.
Results
The study sample included 261 participants, evenly split
between males and females, with the modal age group
between 51 and 70 years of age (Additional file 1). There
were no significant differences between study partici-
pants and patients that did not participate on the char-
acteristics of age or gender which would have indicated
selection bias; see Additional file 1 for a summary of
participants and non-participants.
Analysis of participants’ SNOT-22 scores are provided
in Table 1. The average SNOT-22 score was 42.1. The
results from the univariate analyses show that younger
age tended to be associated with higher SNOT-22 scores
relative to older participants; participants between 31 and
50 years of age had SNOT-22 scores 18 points higher than
participants aged 70 years and older (p < 0.01). Partici-
pants with more comorbidities reported higher SNOT-22
scores than those without – participants with three or
more comorbidities reported SNOT-22 scores 28 points
higher than those participants without comorbidities
(p < 0.01). There were no differences in SNOT-22 scores
between genders (p = 0.16).
Overall, 19.2% of participants reported symptoms as-
sociated with clinical depression. As shown in Table 2,
depression was unevenly reported among the study’s
participants. Those between 31 and 50 years of age re-
ported significantly higher PHQ-9 scores than partici-
pants older than 70 years (p < 0.01). Participants with
more than one comorbidity reported higher levels of de-
pression. Further, participants with three or more comor-
bidities reported PHQ-9 scores 2.7 points higher than
those without any significant comorbidities (p < 0.01).
Among participants, 44.6% reported PEG scores of
three or greater, indicating high pain. Pain was highest
among participants 50 years of age or less; relative to the
Table 1 Multivariate analysis of patients’ SNOT-22 scores, adjusting
for demographics and comorbidities
Model parameter Coefficient Standard error F-Statistic
P-Value
Intercept 19.39 4.88 <0.01
Gender
Male Reference
Female 3.50 2.52 0.16
Age group
< = 30 14.00 6.26 0.02
31–50 18.72 4.67 <0.01




1 4.04 3.41 0.23
2 10.50 3.86 <0.01
3 4.31 4.77 0.36
3+ 28.45 4.12 <0.01
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oldest age group, this age group reported PEG scores 1.6
points higher. There were no differences in pain scores
between genders (p = 0.20). Participants with comorbidi-
ties reported higher pain scores. Participants with three
or more comorbidities reported pain scores 0.78 higher
compared to those with no comorbidities (p < 0.01).
As shown in Table 3, higher SNOT-22 scores were
highly, and independently, associated with depression and
pain scores (both p < 0.01). Adjusting for patient demo-
graphics and comorbidities, each point increase in PHQ-9
score was associated with a 1.41 point increase in SNOT-
22 score (p < 0.01). For a CRS patient with treatable
depression, and PHQ-9 score of 10, there was an expected
increase of 14 points in the participants’ SNOT-22 score.
Pain was also highly significantly associated with SNOT-
22 score after adjusting for patient demographics and
comorbidities (p < 0.01). Each point increase in the PEG
was associated with a 2.42 point increase in SNOT-22
score. This relationship meant that for a patient with high
pain – a PEG score of 3 – there was an expected 7 point
increase in the participants’ SNOT-22 score.
The results of Table 4 show the association between
participants’ quintile of SNOT-22 sleep score and de-
pression and pain. There was a positive association be-
tween sleep scores and depression scores – participants
reporting the most severe problems with sleep were
several-fold more likely to report moderate depression
and high pain as participants with high quality of sleep.
Among participants, patients with significant sleep prob-
lems were at least 80% likely to have at least moderate
depression and high pain.
Discussion
This study focused on patients’ self-reported CRS-
related symptoms at the time they were enrolled on the
VCH’s wait list for ESS. Our primary interest was in the
prevalence of pain and depression, and the relationship
between these morbidities and CRS symptoms (as mea-
sured by the SNOT-22). Younger participants were more
likely to have worse SNOT-22 scores, higher rates of de-
pression and pain after adjusting for other comorbidities.
This finding is important, as the relationship between
the SNOT-22 score (a condition-specific instrument)
and other specific instruments designed to be sensitive
to depression and pain, was previously unclear. These
Table 2 Multivariate analysis of patients’ PHQ-9 and PEG scores,
adjusting for demographics and comorbidities
PHQ-9 PEG
Parameter Coefficient Std Err. P-Value Coefficient Std Err. P-Value
Intercept 2.13 0.21 <0.001 1.35 0.18 <0.01
Gender
Male Reference Reference
Female 0.97 0.11 0.75 1.13 0.09 0.20
Age group
< =30 1.52 0.26 0.11 1.61 0.23 0.04
31–50 1.76 0.2 <0.01 1.62 0.17 <0.01




1 1.03 0.14 0.84 1.33 0.13 0.02
2 1.74 0.16 <0.01 1.72 0.14 <0.01
3 1.61 0.2 0.02 1.83 0.18 <0.01
> 3 3.16 6.58 <0.01 2.39 0.15 <0.01
Table 3 Multivariate analysis of patients’ SNOT-22 scores, adjust-
ing for demographics and comorbidities
Parameter Estimate Standard error F-Statistic
P-Value
Intercept 16.31 4.04 <0.01
Gender
Male Reference
Female 2.68 2.12 0.20
Age group
< = 30 6.53 5.31 0.22
31–50 11.04 3.92 <0.01




1 1.92 2.87 0.50
2 2.44 3.31 0.46
3 −2.66 4.07 0.51
3+ 10.23 3.83 <0.01
Patient-reported outcomes
PHQ-9 1.41 0.26 <0.01
PEG 2.42 0.50 <0.01
Table 4 PHQ-9 and PEG scores shown by quintile of the sleep
function score of SNOT-22
Depression PHQ-9 Pain PEG
SNOT-22 sleep
function score
N Mean (SD) Score > =10
(%)
Mean (SD) Score > =3
(%)
Overall 261 5.2 (5.4) 19.2% 2.9 (2.7) 44.6%
0–8 62 0.8 (1.6) 1.6% 0.7 (1.1) 6.6%
9–16 61 3.5 (3.9) 8.2% 2.3 (2.4) 37.7%
17–24 75 5.6 (3.6) 12.0% 3.2 (2.0) 53.3%
25–32 46 9.4 (5.7) 45.7% 5.2 (2.7) 76.1%
33–40 17 14.4 (6.1) 82.4% 6.0 (3.2) 82.4%
PHQ-9 scores of ten above and PEG scores of three and above are associated
with moderate depression and high pain, respectively
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are important domains which have been previously re-
ported to be inadequately measured by the SNOT-22
[21], though the effects of which have been suggested
elsewhere [11, 13].
The results also found that the worst pain and depres-
sion was reported by a subset of patients with severe
sleep problems. Indeed, relationships between depres-
sion, pain and sleep have been raised by others [15]. The
associations between these factors in this study suggest
that surgeons could prioritize patients, and improve
health status, on the basis of sleep problems alone.
The implications of these findings are substantial. Since
this study’s participants’ SNOT-22 scores were comparable
to those reported in literature [17, 22, 23], there is very
likely to be substantial depression and pain among the
population of patients waiting for ESS. In light of these
findings, an effective strategy for improving global health
could consider complementary non-surgical interventions
for depression and pain, focused on patients whose pre-
surgical SNOT-22 scores were in the highest quintile,
reporting a number of comorbid conditions or reporting
poor sleep quality.
There are some limitations of these findings. Study
participants were a subset of patients recruited from the
VCH wait list, though there was no evidence to believe
that patients participating in this study were substan-
tially different from those that declined to participate.
Nor do these findings mean that the results are true in all
regions of Canada. Finally, as this was a cross-sectional
analysis, one cannot draw conclusions regarding possible
causal pathways between waiting for ESS for CRS and
physical and mental health.
The knowledge generated from this study is timely
from a policy perspective, as BC has been directing
additional funding into elective surgeries to reduce
wait times [24]. The process used to generate patient-
reported outcomes data for this study will also have
an impact on BC’s Ministry of Health, the funder
seeking to improve the patient-centredness of surgical
treatment in the province [25], by identifying gaps in
medical treatment related to its management of surgi-
cal wait lists.
Conclusion
CRS is a highly prevalent condition and its treatment by
ESS is very common. This study underscores that ap-
proximately one-fifth of patients waiting for ESS report
clinically significant depression and/or pain. While an
Otolaryngologist should be attentive to pain and depres-
sive symptoms in all patients, when faced with lengthy
waits for ESS, multi-disciplinary treatment, such as
involving psychologists or pain management, is indi-
cated for patients who pre-operatively screen with
high SNOT-22 scores.
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